Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
(3-Chlorophenyl)boronic acid → [1-(3-Chloro-phenyl)-5-(4-isopropyl-piperazine-1-carbonyl)-1H-indol-2-yl]-[4-(piperidine-1-carbonyl)-piperazin-1-yl]-methanone
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | (3-Chlorophenyl)boronic acid | HCID 2734323 | — |
| 반응물 | {4-[5-(4-Isopropyl-piperazine-1-carbonyl)-1H-indole-2-carbonyl]-piperazin-1-yl}-piperidin-1-yl-methanone | HCID 68533742 | — |
| 생성물 | [1-(3-Chloro-phenyl)-5-(4-isopropyl-piperazine-1-carbonyl)-1H-indol-2-yl]-[4-(piperidine-1-carbonyl)-piperazin-1-yl]-methanone | HCID 68536874 | 49% |
반응 단계
The title compound was synthesized in analogy to example 5, from {4-[5-(4-isopropyl-piperazine-1-carbonyl)-1H-indole-2-carbonyl]-piperazin-1-yl}-piperidin-1-yl-methanone (example 14) and 3-chlorophenylboronic acid to afford the desired product as a light-brown foam (49%). MS (ISP): 605.2 (M+H)+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07648979B2 |
| 출처 데이터셋 | uspto-grants-2010_01 |
| ORD ID | ord-283f2d610ec44b45a58c9d8632e050f4 |
| 출처 메모 | uspto-grants-2010_01 |